Use of a Long-acting Inhaled β2-Adrenergic Agonist, Salmeterol Xinafoate, in Patients with Chronic Obstructive Pulmonary Disease-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Use of a Long-acting Inhaled β2-Adrenergic Agonist, Salmeterol Xinafoate, in Patients with Chronic Obstructive Pulmonary Disease

Published:2001-04 Issue:5 Volume:163 Page:1087-1092
ISSN:1073-449X
Container-title:American Journal of Respiratory and Critical Care Medicine
language:en
Short-container-title:Am J Respir Crit Care Med

Author:

RENNARD STEPHEN I.,ANDERSON WAYNE,ZuWALLACK RICHARD,BROUGHTON JOSEPH,BAILEY WILLIAM,FRIEDMAN MITCHELL,WISNIEWSKI MICHAEL,RICKARD KATHLEEN

Publisher

American Thoracic Society

Subject

Critical Care and Intensive Care Medicine,Pulmonary and Respiratory Medicine

Reference22 articles.

1. Optimal assessment and management of chronic obstructive pulmonary disease (COPD)

2. The pharmacology of salmeterol

3. Sustained Activation of a G Protein-coupled Receptor via “Anchored” Agonist Binding

4. Salmeterol provides prolonged protection against exercise-induced bronchoconstriction in a majority of subjects with mild, stable asthma

Cited by 209 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Data Reproducibility and Effectiveness of Bronchodilators for Improving Physical Activity in COPD Patients;Journal of Clinical Medicine;2020-10-29

2. Chronic Obstructive Pulmonary Disease: A Palliative Medicine Review of the Disease, Its Therapies, and Drug Interactions;Journal of Pain and Symptom Management;2020-07

3. Safety and Adverse Events after Targeted Lung Denervation for Symptomatic Moderate to Severe Chronic Obstructive Pulmonary Disease (AIRFLOW). A Multicenter Randomized Controlled Clinical Trial;American Journal of Respiratory and Critical Care Medicine;2019-12-15

4.

Relationship of inhaled long-acting bronchodilators with cardiovascular outcomes among patients with stable COPD: a meta-analysis and systematic review of 43 randomized trials

;International Journal of Chronic Obstructive Pulmonary Disease;2019-04

5. The efficacy of adding budesonide/formoterol to ipratropium plus theophylline in managing severe chronic obstructive pulmonary disease: an open-label, randomized study in China;Therapeutic Advances in Respiratory Disease;2019-01

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3